Presynaptic GABAB-and γ-hydroxybutyric acid-mediated mechanisms in generalized absence seizures

Neuropharmacology

Volumn 35, Issue 3, 1996, Pages 359-367

  Snead III, O C ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (Canada)

Author keywords

Absence seizures; GABA; GABAB receptor; hydroxybutyric acid (GHB)

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CALCIUM; OXYBATE SODIUM; RUBIDIUM; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 HYDROXYBUTYRIC ACID; OMEGA CONOTOXIN; PHACLOFEN; POTASSIUM CHANNEL;

ANIMAL; ARTICLE; BRAIN CORTEX; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; SYNAPTOSOME; ANIMAL TISSUE; AUTORADIOGRAPHY; BINDING SITE; BRAIN SYNAPTOSOME; CALCIUM TRANSPORT; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; BACLOFEN; CALCIUM; CEREBRAL CORTEX; GABA MODULATORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RUBIDIUM; SODIUM OXYBATE; SYNAPTOSOMES;

EID: 0029659008     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00181-6     Document Type: Article

References (59)

1. 3H]-γ-hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience 56: 11-21.
2. 2+-dependent glutamate and GABA release by γ-hydroxybutyric acid in the thalamic ventrobasal nucleus. J. Pharmac. Exp. Ther. 273: 1534-1543.
3. Bartschat D. K. and Blaustein M. P. (1985a) Potassium channels in isolated presynaptic nerve terminals from rat brain. J. Physiol. 361: 419-440.
4. Bartschat D. K. and Blaustein M. P. (1985b) Calcium-activated potassium channels in presynaptic nerve terminals from rat brain. J. Physiol. 361: 441-457.
5. Benavides J., Rumigny J. F., Bourguignon J. J., Wermuth C. G., Mandel P. and Maitre M. (1982) High affinity binding sites for γ-hydroxybutyric acid in rat brain. Life Sci. 30: 953-961.
6. Berkovic S. F., Andermann F., Andermann E., and Gloor P. (1987) Concepts of absence epilepsies: discrete syndromes or biologic continuum? Neurology 37: 993-1000.
7. B receptors. J. Neural Trans. 35 (Suppl): 155-178.
8. B receptor antagonists: from synthesis to therapeutic applications. Trends Pharmac. Sci. 14: 391-394.
9. Bonanno G., Fontana G. and Raiteri M. (1988) Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex. Eur. J. Pharmac. 154: 223-224.
10. B autoreceptors in rat cortex synaptosomes: response under different depolarizing and ionic conditions. Eur. J. Pharmac. 172: 41-49.
11. B receptor subtypes in the rat cerebral cortex. J. Pharmac. Exp. Ther. 262: 114-118.
12. B receptors. Trends Pharmac. Sci. 14: 259-261.
13. Calabresi P., Mercuri, N. B., De Murtas M. and Bernardi G. (1991) Involvement of GABA systems in feedback regulation of glutamate-and GABA-mediated synaptic potentials in rat neostriatum. J. Physiol. 440: 581-599.
14. (o): antisense oligonucleotide studies. J. Physiol. Lond. 470: 1-11.
15. B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 14: 16-21.
16. B receptor feedback on GABA release. J. Physiol. Lond. 412: 513-541.
17. Depaulis A., Bourguignon J. J., Marescaux C., Vergnes M., Schmitt M., Micheletti G., and Warter J. M. (1988) Effect of γ-hydroxybutyrate and γ-butyrolactone derivatives on spontaneous generalized non-convulsive seizures in the rat. Neuropharmacology 27: 6863-6869.
18. + channels of large conductance in rat brain synaptosomes. Biophys. J. 53: 919-934.
19. Farrar R. P., Rezazadeh S. M., Morris J. L., Dildy J. E., Gnau K. and Leslie S. W. (1989) Aging does not alter cytosolic calcium levels of cortical synaptosomes in Fischer 344 rats. Neurosci. Lett. 100: 319-325.
20. Gloor P. and Fariello R. G. (1988) Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci. 11: 63-68.
21. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
22. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 239: 57-61.
23. B receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257: 398-401.
24. 125I]ω-conotoxin in rat brain. Eur. J. Pharmac. 146: 181-183.
25. B neurotransmission in the control of absence seizures in the rat. Neuroscience 48: 87-93.
26. Lockman L. A. (1989) Absence, myoclonic, and atonic seizures. Ped. Clin. N. Am. 36: 331-343.
27. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. 2+ channel. Eur. J. Pharmac. 206: 61-68.
29. Maitre M., Hechler V., Vayer P., Gobaille S., Cash C. D., Schmidtt M. and Bourguignon J. J. (1990) A specific γ-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J. Pharmac. Exp. Ther. 255: 657-663.
30. McCormick D. A. (1992) Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol. 39: 337-388.
31. 2+ channels in cultured dorsal root ganglion cells. Pflugers Archiv. Eur. J. Physiol. 425: 335-343.
32. Miller R. J. (1987) Multiple calcium channels and neuronal function. Science 235: 46-52.
33. Nowycky M., Fox A. P. and Tsien R. Y. (1985) Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316: 440-443.
34. O'Shaughnessy C. T. and Lodge D. (1988) N-methyl-D-aspartate receptor-mediated increase in calcium is reduced by ketamine and phencyclidine. Eur. J. Pharmac. 153: 201-209.
35. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
36. Scanziani M., Cpogna M., Gahwiler B. H. and Thompson S. M. (1992) Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus. Neuron 9: 919-927.
37. + channels and block neurosecretion. Proc. Natn. Acad. Sci. U.S.A. 87: 3489-3492.
38. Sher E. and dementi F. (1991) ω-Conotoxin-sensitive voltage-operated calcium channels in vertebrate cell. Neuroscience 42: 301-307.
39. Sherwin A. (1989) Clinical use of ethosuximide. In Anti-epileptic Drugs (Levy R. H., Mattson R. H., Meldrum B. S., Penry J. K., eds.) pp. 685-698. Raven Press, New York.
40. 2+ currents and synaptic transmission in cultured rat hippocampal neurones. J. Physiol. 444: 669-686.
41. Snead O. C. and Hosey L. C. (1985) Exacerbation of seizures in children by carbamazepine. N. Eng. J. Med. 313: 916-921.
42. Snead O. C. and Nichols A. C. (1987) γ-Hydroxybutyric acid binding sites: evidence for coupling to a chloride anion channel. Neuropharmacology 26: 1519-1523.
43. Snead O. C. (1988) γ-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 29: 361-368.
44. Snead O. C. (1991) The γ-hydroxybutyrate model of absence seizures: correlation of regional brain levels of γ-hydroxybutyric acid and γ-butyrolactone with spike wave discharges. Neuropharmacology 30: 163-167.
45. B-mediated mechanisms in experimental absence seizures. Eur. J. Pharmac. 213: 343-349.
46. Snead O. C. (1992b) Pharmacologic models of absence seizures. J. Neural Trans. Supp. 35: 7-20.
47. B binding sites in rat brain: G-protein studies. Epilepsia 35(Suppl 8): 85.
48. B binding sites: relation to the development of experimental absence seizures. Brain Res. 659: 147-156.
49. B and γ-hydroxybutyric acid (GHB) receptor antagonists. Pharmac. Blochem. Behav. in press.
50. 125I]ω-conotoxin GVIA binding to neuronal membranes by neomycin may be mediated by a GTP-binding protein. Eur. J. Pharmac. 206: 155-158.
51. Takemura M., Kiyama H., Fukui H., Tohyama M. and Wada H. (1988) Autoradiographic visualization in rat brain of receptors for ω-conotoxin GVIA, a newly discovered calcium antagonist. Brain Res. 451: 386-389.
52. 2+ channels in rat sensory neurons. Neurosci. Lett. 127: 49-52.
53. 2+-activated potassium channels in synaptosomes: involvement of G-proteins. Life Sci. 44: 1271-1276.
54. Vergnes M., Marescaux C. and Depaulis A. (1990) Mapping of spontaneous spike and wave discharges in Wistar rats with genetic generalized non-convulsive epilepsy. Brain Res. 523: 87-91.
55. Walker J. H. and Agoston D. V. (1987) The synaptic vesicle and the cytoskeleton. Biochem. J. 247: 249-258.
56. B receptors. Soc. Neurosci. Abstr. 19: 527.
57. Woodward J. J., Machu T. and Leslie S. W. (1990) Chronic ethanol treatment alters ω-conotoxin and Bay K 8644 sensitive calcium channels in rat striatal synaptosomes. Alcohol 7: 279-284.
58. Woodward J. J., Rezazadeh M. and Leslie S. W. (1988) Differential sensitivity of synaptosomal calcium entry and endogenous dopamine release to ω-conotoxin. Brain Res. 475: 141-45.
59. B receptors. Eur. J. Pharmac. 212: 291-294.